You’ve probably experienced a few different types of acne since your teenage years, from annoying blackheads to juicy papules. But if you’ve ever developed one of those large, deep, painful red pimples that doesn’t go away, and sometimes never comes to a head, you know it’s a different beast altogether. If you’ve been slathering your… Read More »
FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis Print this page SUMMIT, N.J.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved Inrebic (fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.1 “The approval… Read More »
FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »
May 24, 2019 — The FDA has approved the first new treatment in 15 years for an aggressive form of lung cancer. The device, the NovoTTF-100L System made by Novocure, uses electric fields to stop solid tumors from mesothelioma from dividing. Mesothelioma is a rare but aggressive cancer strongly associated with asbestos exposure. The new… Read More »
Minor vaginal cuts and tears are common and often occur when a person is removing body hair or engaging in sexual activity. People with certain hormonal, skin, and immune conditions may be more likely to get vaginal cuts or tears. Minor vaginal wounds are usually harmless, but they may cause mild pain and discomfort for… Read More »